rs420549
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004612.4(TGFBR1):c.*3286G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 228,664 control chromosomes in the GnomAD database, including 3,248 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2071 hom., cov: 32)
Exomes 𝑓: 0.17 ( 1177 hom. )
Consequence
TGFBR1
NM_004612.4 3_prime_UTR
NM_004612.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.462
Publications
18 publications found
Genes affected
TGFBR1 (HGNC:11772): (transforming growth factor beta receptor 1) The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TGFBR1 Gene-Disease associations (from GenCC):
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Loeys-Dietz syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Loeys-Dietz syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P
- multiple self-healing squamous epitheliomaInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 9-99152591-G-C is Benign according to our data. Variant chr9-99152591-G-C is described in ClinVar as Benign. ClinVar VariationId is 364164.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.197 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TGFBR1 | NM_004612.4 | c.*3286G>C | 3_prime_UTR_variant | Exon 9 of 9 | ENST00000374994.9 | NP_004603.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TGFBR1 | ENST00000374994.9 | c.*3286G>C | 3_prime_UTR_variant | Exon 9 of 9 | 1 | NM_004612.4 | ENSP00000364133.4 |
Frequencies
GnomAD3 genomes AF: 0.158 AC: 24073AN: 152046Hom.: 2073 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24073
AN:
152046
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.168 AC: 12877AN: 76500Hom.: 1177 Cov.: 0 AF XY: 0.170 AC XY: 5997AN XY: 35374 show subpopulations
GnomAD4 exome
AF:
AC:
12877
AN:
76500
Hom.:
Cov.:
0
AF XY:
AC XY:
5997
AN XY:
35374
show subpopulations
African (AFR)
AF:
AC:
434
AN:
3664
American (AMR)
AF:
AC:
281
AN:
2360
Ashkenazi Jewish (ASJ)
AF:
AC:
878
AN:
4798
East Asian (EAS)
AF:
AC:
642
AN:
10914
South Asian (SAS)
AF:
AC:
88
AN:
650
European-Finnish (FIN)
AF:
AC:
53
AN:
302
Middle Eastern (MID)
AF:
AC:
66
AN:
468
European-Non Finnish (NFE)
AF:
AC:
9293
AN:
46972
Other (OTH)
AF:
AC:
1142
AN:
6372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
525
1051
1576
2102
2627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.158 AC: 24079AN: 152164Hom.: 2071 Cov.: 32 AF XY: 0.152 AC XY: 11276AN XY: 74394 show subpopulations
GnomAD4 genome
AF:
AC:
24079
AN:
152164
Hom.:
Cov.:
32
AF XY:
AC XY:
11276
AN XY:
74394
show subpopulations
African (AFR)
AF:
AC:
5365
AN:
41526
American (AMR)
AF:
AC:
2006
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
661
AN:
3470
East Asian (EAS)
AF:
AC:
73
AN:
5194
South Asian (SAS)
AF:
AC:
504
AN:
4824
European-Finnish (FIN)
AF:
AC:
1385
AN:
10590
Middle Eastern (MID)
AF:
AC:
45
AN:
292
European-Non Finnish (NFE)
AF:
AC:
13555
AN:
67958
Other (OTH)
AF:
AC:
340
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1049
2098
3146
4195
5244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
224
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Loeys-Dietz syndrome 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Loeys-Dietz syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.